Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
142.00    0.00 (0.00%)
Bid:
142.00
Ask:
149.00
Spread: 7.00 (4.93%)
Market Cap: £272.19m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Share Purchase Programme

26 Jun 2023 07:00

RNS Number : 7849D
Franchise Brands PLC
26 June 2023
 

26 June 2023

FRANCHISE BRANDS PLC

("Franchise Brands", the "Group" or "the Company")

 

Share purchase programme

 

Franchise Brands plc (AIM: FRAN), an international multi-brand franchise business, announces that it will continue its discretionary programme to buy ordinary shares of 0.5p each in the Company ("Ordinary Shares") for the next six-month period from 1 July 2023 to 31 December 2023, up to an aggregate value of £1,500,000 (the "Programme").

 

The Trustee of the Franchise Brands PLC Employee Benefit Trust (the "EBT") will purchase Ordinary Shares in accordance with the Programme. The Programme seeks to mitigate the dilutive impact of share option awards and to improve overall shareholder return.

 

During the period 23 December 2023 to 23 June 2023 ("the Period"), the EBT has purchased 18,420 Ordinary Shares at an average price of £2.00 pence per share. 10,500 Ordinary Shares held by the EBT have been used to satisfy the exercise of options over Ordinary Shares during the Period. Accordingly, the EBT currently holds 1,782,835 Ordinary Shares (23 December 2022: 1,774,915 Ordinary Shares) which represents 0.92 per cent. (23 December 2022: 1.36 per cent.) of the Company's current issued share capital. The net cash cost to the Company during the period was £37,045.

 

The Trustees of the EBT have entered into arrangements with the Company's joint broker, Dowgate Capital Limited ("Dowgate"), to carry out on-market purchases of Ordinary Shares under the Programme, including on a discretionary basis independent of the Company during any prohibited periods of the Company, as determined by the UK Market Abuse Regulation, which may fall during the period of the Programme.

 

Enquiries:

 

Franchise Brands plc

+ 44 (0) 1625 507 910

Stephen Hemsley, Executive Chairman

Andrew Mallows, Interim Chief Financial Officer

Julia Choudhury, Corporate Development Director

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / George Payne (Corporate Finance)

Amrit Nahal (Sales & Corporate Broking)

 

Dowgate Capital Limited (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant / Russell Cook / Nicholas Chambers

 

 

Stifel Nicolaus Europe Limited (Joint Broker)

+44 (0) 20 7710 7699

Matthew Blawat / Francis North

 

 

 

MHP Group (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt / Catherine Chapman

+44 (0) 7884 494112

franchisebrands@mhpgroup.com

 

About Franchise Brands plc

 

Franchise Brands is an international, multi-brand franchisor focused on building market-leading businesses primarily via a franchise model. The Group has a combined network of 650 franchisees across seven franchise brands in ten countries covering the UK, North America and Europe.

 

Franchise Brands' focus is on B2B van-based reactive and planned services. The Company owns several market-leading brands with a long trading history, including Metro Rod, Metro Plumb, Filta and Pirtek in Europe, all of which benefit from the Group's central support services, in particular technology, marketing, management experience and other group resources. At the centre of Franchise Brands' business building strategy is helping its franchisees grow their businesses: "if they grow, we grow".

 

Franchise Brands employs some 690 people across the Group.

 

For further information, visit www.franchisebrands.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLSRFIVFIV
Date   Source Headline
26th May 202612:58 pmRNSGrant of Options to director
18th May 20267:00 amRNSAppointment of new CFO & Group Delivery Director
30th Apr 20264:01 pmRNSResult of General Meeting
30th Apr 20264:00 pmRNSResult of Annual General Meeting
30th Apr 20267:00 amRNSAGM Statement and Q1 Trading Update
7th Apr 202612:29 pmRNSHolding(s) in Company
31st Mar 20265:13 pmRNSProposed Share Premium cancellation
31st Mar 20265:13 pmRNSAnnual Report and Accounts & Notice of AGM
27th Mar 20267:00 amRNSGrant of Options to directors
27th Mar 20267:00 amRNSDirectors’ dealings
26th Mar 20267:00 amRNSDirectors' dealings
25th Mar 20267:00 amRNSFinal Results
18th Mar 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Mar 20263:13 pmRNSHolding(s) in Company
11th Mar 20263:13 pmRNSHolding(s) in Company
5th Mar 202611:17 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSNotice of Results
2nd Mar 20262:00 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update
21st Jan 20263:00 pmRNSHolding(s) in Company
21st Jan 20262:55 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
12th Nov 20257:00 amRNSQ3 Trading Update
3rd Nov 20252:00 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSDirectors’ dealings
14th Oct 20257:00 amRNSEBT share purchase programme update
9th Oct 20253:48 pmRNSDirectors’ dealings – Replacement
9th Oct 20257:00 amRNSDirectors' dealings
1st Oct 20255:00 pmRNSDirectors’ dealings
29th Sep 20256:05 pmRNSDirectors’ dealings
23rd Sep 20252:00 pmRNSHolding(s) in Company
5th Aug 20258:46 amRNSUpdate on potential listing
31st Jul 20251:52 pmRNSGrant of Options to director
30th Jul 20257:00 amRNSInterim Results
21st Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jul 20257:00 amRNSNotice of Interim Results
23rd Jun 20257:00 amRNS-RInclusion in FTSE AIM UK 50 Index
28th May 202511:06 amRNSHolding(s) in Company
19th May 20257:00 amRNSMove to SETS
7th May 20253:00 pmRNSResult of AGM
7th May 20257:00 amRNSAGM Statement and Q1 Trading Update
9th Apr 202510:00 amRNSDirectors' dealings
8th Apr 202510:00 amRNSDirectors' dealings
7th Apr 202510:00 amRNSDirectors’ dealings
4th Apr 20254:00 pmRNSHolding(s) in Company
2nd Apr 20259:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:00 amRNSFinal Results
17th Mar 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.